K Örnek, N Örnek - Journal of Ocular Pharmacology and Therapeutics, 2008 - liebertonline.com Introduction D IABETIC MACULAR EDEMA (DME) is still the main cause of visual
loss in patients with diabetic retinopathy. Treat- ment of DME includes macular
laser photocoagulation (MLP), pars plana vitrectomy (PPV), and the ... Cited by 4 - Related articles - All 3 versions
DJ Browning, MM Altaweel, NM Bressler, SB … - American Journal of Ophthalmology, 2008 - v2020la.org ● PURPOSE: To review the available information on classification of diabetic
macular edema (DME) as focal or diffuse. ● DESIGN: Interpretive essay. ●
METHODS: Literature review and interpretation. ● RESULTS: The terms focal ... Cited by 2 - Related articles - View as HTML - All 5 versions
O Çekiç, Y Bardak, ŞU Tığ, A Demirkol, MM Ekim … - International Ophthalmology, 2007 - Springer Abstract Purpose To assess ocular hemodynamic response to intravitreal
triamcinolone in patients with macular edema due to diabetes or retinal vein
occlusion. Methods Forty-three patients that were injected by intravitreal ... Cited by 1 - Related articles - BL Direct - All 2 versions
M Ilavska - Bratisl Lek Listy, 2009 - bratislleklisty.sk Diabetic retinopathy is a late complication of diabetes melli- tus. There are
two causes for vision deterioration or blindness diabetic maculopathy and
complications accompanying the ori- gin and the development of diabetic ... Related articles - All 3 versions